Clinical Trial

Pivotal U.S. Clinical Validation of AI-COA® for Depression and Anxiety

Name: Pivotal U.S. Clinical Validation of AI-COA® for Depression and Anxiety — clinical trial record (NCT07279038)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SEQUOIA-3

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This study is a large-scale pivotal clinical validation of the AI-COA® software device. The purpose is to confirm the tool's accuracy and performance across a demographically diverse population of adults with Major Depressive Disorder (MDD), ensuring it functions fairly and reliably across different subgroups.

Trial Details

NCT Number	NCT07279038
Lead Sponsor	Deliberate Solutions Inc. Collaborators: Baylor College of Medicine, National Institute of Mental Health (NIMH)
Conditions	Depression Disorders, Anxiety Disorders
Enrollment	650 participants
Start Date	2027-03-01
Primary Completion	2029-08-28 (estimated)
Study Completion	2029-08-28 (estimated)
Updated on ClinicalTrials.gov	2025-12-12